Well Lead Med Co Ltd (603309) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Well Lead Med Co Ltd (603309) has a cash flow conversion efficiency ratio of 0.065x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥126.26 Million ≈ $18.48 Million USD) by net assets (CN¥1.95 Billion ≈ $284.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Well Lead Med Co Ltd worth for the company's overall valuation and market capitalisation.
Well Lead Med Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Well Lead Med Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Well Lead Med Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Well Lead Med Co Ltd ranked by their cash flow conversion efficiency. Explore Well Lead Med Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dalian Thermal Power Co Ltd
SHG:600719
|
0.574x |
|
YIDU TECH INC. DL -00002
F:0EL
|
N/A |
|
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
|
-0.048x |
|
Ibersol SGPS
LS:IBS
|
0.082x |
|
Shanghai Join Buy Co Ltd
SHG:600838
|
0.003x |
|
Zuming Bean Products Co Ltd
SHE:003030
|
0.007x |
|
Stenhus Fastigheter I Norden AB
ST:SFAST
|
0.021x |
|
Fujian Green Pine Co Ltd
SHE:300132
|
-0.038x |
Annual Cash Flow Conversion Efficiency for Well Lead Med Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Well Lead Med Co Ltd from 2011 to 2025. View today's stock price for Well Lead Med Co Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.78 Billion ≈ $259.96 Million |
CN¥330.26 Million ≈ $48.33 Million |
0.186x | +15.52% |
| 2024-12-31 | CN¥1.90 Billion ≈ $278.48 Million |
CN¥306.26 Million ≈ $44.82 Million |
0.161x | +26.59% |
| 2023-12-31 | CN¥1.84 Billion ≈ $268.80 Million |
CN¥233.51 Million ≈ $34.17 Million |
0.127x | -43.45% |
| 2022-12-31 | CN¥1.74 Billion ≈ $254.58 Million |
CN¥391.13 Million ≈ $57.23 Million |
0.225x | +91.04% |
| 2021-12-31 | CN¥1.59 Billion ≈ $232.89 Million |
CN¥187.28 Million ≈ $27.41 Million |
0.118x | -41.07% |
| 2020-12-31 | CN¥1.14 Billion ≈ $167.40 Million |
CN¥228.44 Million ≈ $33.43 Million |
0.200x | +15.76% |
| 2019-12-31 | CN¥1.04 Billion ≈ $151.66 Million |
CN¥178.79 Million ≈ $26.16 Million |
0.173x | +80.42% |
| 2018-12-31 | CN¥940.07 Million ≈ $137.56 Million |
CN¥89.89 Million ≈ $13.15 Million |
0.096x | +15.77% |
| 2017-12-31 | CN¥900.07 Million ≈ $131.71 Million |
CN¥74.34 Million ≈ $10.88 Million |
0.083x | -16.45% |
| 2016-12-31 | CN¥863.31 Million ≈ $126.33 Million |
CN¥85.35 Million ≈ $12.49 Million |
0.099x | -5.51% |
| 2015-12-31 | CN¥778.65 Million ≈ $113.94 Million |
CN¥81.47 Million ≈ $11.92 Million |
0.105x | -63.92% |
| 2014-12-31 | CN¥370.18 Million ≈ $54.17 Million |
CN¥107.34 Million ≈ $15.71 Million |
0.290x | +20.35% |
| 2013-12-31 | CN¥302.37 Million ≈ $44.25 Million |
CN¥72.85 Million ≈ $10.66 Million |
0.241x | -27.81% |
| 2012-12-31 | CN¥249.37 Million ≈ $36.49 Million |
CN¥83.23 Million ≈ $12.18 Million |
0.334x | +46.46% |
| 2011-12-31 | CN¥193.41 Million ≈ $28.30 Million |
CN¥44.08 Million ≈ $6.45 Million |
0.228x | -- |
About Well Lead Med Co Ltd
Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guid… Read more